Temporal Changes in Targeted Temperature Management for Out-of-Hospital Cardiac Arrest-Examining the Effect of the Targeted Temperature Management Trial: A Retrospective Cohort Study.


Journal

Therapeutic hypothermia and temperature management
ISSN: 2153-7933
Titre abrégé: Ther Hypothermia Temp Manag
Pays: United States
ID NLM: 101543518

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 18 12 2020
medline: 15 12 2021
entrez: 17 12 2020
Statut: ppublish

Résumé

Targeted temperature management (TTM) is recommended after out-of-hospital cardiac arrest (OHCA). However, interpretation of the evidence and translation into clinical practice, to realize benefits to patient outcomes may be inconsistent. This study aims to compare compliance with the recommended targeted temperatures and the use of intravascular temperature management (IVTM), as well as 90-day survival, before and after publication of the TTM trial. A single-center retrospective cohort study was conducted from 2010 to 2017. All comatose patients admitted to the intensive care unit after OHCA, who survived for ≥24 hours, were included. IVTM use was measured and TTM adherence was defined as the percentage time the core temperature was (1) within the guideline-recommended temperature range (initially 32-34°C, later modified to 32-36°C) for the first 24 hours, and (2) ≤37.5°C between 24 and 72 hours following admission. Multiple logistic regression analyses were performed for the use of IVTM and survival at 90 days. Of the 302 patients identified, 136 (45%) were pre-TTM, and 166 (55%) post-TTM. Baseline characteristics were similar between the groups. IVTM use decreased significantly (77.9% vs. 51.8%,

Identifiants

pubmed: 33332235
doi: 10.1089/ther.2020.0028
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-237

Auteurs

Benjamin Garfield (B)

Department of Critical Care, Guy's and St. Thomas', King's College London, London, United Kingdom.

Mohammad Yusuf Abdoolraheem (MY)

Chelsea and Westminster NHS Foundation Trust, London, United Kingdom.

Alison Dixon (A)

Department of Critical Care, Guy's and St. Thomas', King's College London, London, United Kingdom.

Andrew Aswani (A)

Department of Critical Care, Guy's and St. Thomas', King's College London, London, United Kingdom.

Richard Paul (R)

Department of Critical Care, Guy's and St. Thomas', King's College London, London, United Kingdom.

Peter Sherren (P)

Department of Critical Care, Guy's and St. Thomas', King's College London, London, United Kingdom.

Guy Glover (G)

Department of Critical Care, Guy's and St. Thomas', King's College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH